HF
GTHX

HRT Financial’s G1 Therapeutics, Inc. Common Stock GTHX Stock Holding History

HRT Financial’s Portfolio GTHX Stock Details GTHX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-140,909
Closed -$608K – 3322
2024
Q1 		$608K Buy
+140,909
New +$491K ﹤0.01% 1155
2023
Q2 		– Sell
-144,780
Closed -$388K – 3490
2023
Q1 		$388K Buy
144,780
+37,505
+35% +$180K ﹤0.01% 1563
2022
Q4 		$582K Buy
+107,275
New +$899K 0.01% 1313
2022
Q2 		– Sell
-204,066
Closed -$1.55M – 3916
2022
Q1 		$1.55M Buy
+204,066
New +$1.94M 0.01% 756

Other funds holding GTHX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return
RJA
Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

HRT Financial's GTHX Position: Q2 2024 in Review

HRT Financial sold out of G1 Therapeutics, Inc. Common Stock (GTHX) in Q2 2024, closing a stake of 140,909 shares — an estimated $608K sold.

HRT Financial first reported a position in GTHX in Q1 2022 and held it in 4 quarters. The position peaked at $1.55M in Q1 2022. 88 funds tracked by Wall St. Rank hold GTHX as of Q2 2024.

  • HRT Financial reported no remaining G1 Therapeutics, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
  • HRT Financial sold 140,909 G1 Therapeutics, Inc. Common Stock shares in Q2 2024, an estimated $608K.
  • HRT Financial first reported a position in G1 Therapeutics, Inc. Common Stock in Q1 2022 and held it in 4 quarters.
  • HRT Financial's G1 Therapeutics, Inc. Common Stock position peaked at $1.55M in Q1 2022.
  • 88 funds tracked by Wall St. Rank held G1 Therapeutics, Inc. Common Stock as of Q2 2024.

Based on HRT Financial's 13F filing for Q2 2024, filed 12 Aug 2024.